**Louisiana Classifies Abortion Drugs as Controlled Substances, Sparking Controversy**

Louisiana has become the first state to classify mifepristone and misoprostol, two drugs used for medicated abortions, as controlled substances. This controversial law went into effect on October 1, causing significant concern among medical professionals who warn it could delay essential, life-saving care for some patients.

With the new classification, these drugs must now be stored securely under lock and key, as stipulated by the Louisiana Department of Health. Anyone caught in possession of these medications without a valid prescription could face severe legal consequences, including a prison sentence of up to five years and a fine reaching $5,000.

The New Orleans City Council has already taken steps to address potential issues arising from this law. Last week, it requested the city's health department to "investigate and study any delay of care issues" that might result from these new regulations.

Initially, the bill aimed to make it illegal to administer abortion drugs without the recipient's knowledge. However, an amendment later added the reclassification of these drugs as controlled substances, significantly broadening the bill's scope.

Louisiana’s decision could set a precedent, with other states possibly considering similar measures. This development highlights a growing and contentious debate over reproductive rights and access to medical care.